Absorption, Metabolism and Excretion of Di(rho-aminophenyl) Sulphone (dapsone) and Di(rho-aminophenyl) Sulphoxide in Man

Overview

Journal Br J Pharmacol Chemother

Specialty Pharmacology

Date 1966 Jan 1

PMID 5919504

Citations 11

Authors

G A Ellard

Affiliations

Soon will be listed here.

Citing Articles

Dapsone-Induced Hypoxia.

Keerty D, Eaton K, Haynes E Cureus. 2020; 12(7):e9334.

PMID: 32714715 PMC: 7377661. DOI: 10.7759/cureus.9334.

Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.

Schalcher T, Borges R, Coleman M, Batista Junior J, Salgado C, Vieira J PLoS One. 2014; 9(1):e85712.

PMID: 24465659 PMC: 3899049. DOI: 10.1371/journal.pone.0085712.

Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.

Ahmad R, Rogers H Eur J Clin Pharmacol. 1980; 17(2):129-33.

PMID: 7371704 DOI: 10.1007/BF00562621.

A rapid method for determination of acetylation phenotype using dapsone.

Philip P, Roberts M, Rogers H Br J Clin Pharmacol. 1984; 17(4):465-9.

PMID: 6721993 PMC: 1463405. DOI: 10.1111/j.1365-2125.1984.tb02373.x.

N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.

UEHLEKE H, Tabarelli S Naunyn Schmiedebergs Arch Pharmacol. 1973; 278(1):55-68.

PMID: 4145470 DOI: 10.1007/BF00501863.

References

BUU-HOI N, NGUYEN-BA-KHUYEN , NGUYEN-DAT-XUONG . [Six months of antileprous treatment in South Vietnam with 4,4'-diaminodiphenylsulfoxide and 4,4'-diethoxythiocarbanilide]. Bull Acad Natl Med. 1955; 139(15-16):275-80. View

Bushby S . The chemotherapy of leprosy. Pharmacol Rev. 1958; 10(1):1-42. View

CHATTERJEE K, Poddar R . Radioactive tracer studies on uptake of di-amino-diphenyl-sulphone by leprosy patients. Proc Soc Exp Biol Med. 1957; 94(1):122-5. DOI: 10.3181/00379727-94-22875. View

Lowe J . Studies in sulphone therapy. Lepr Rev. 1952; 23(1):4-29. DOI: 10.5935/0305-7518.19520002. View

LAVIRON P, LAURET L, KERBASTARD P, Jardin C . [4, 4'-Diaminodiphenylsulfoxide in the treatment of leprosy]. Bull Acad Natl Med. 1957; 141(9-10):195-204. View

Bushby S, WOIWOD A . The identification of the major diazotizable metabolite of 4:4'-diaminodiphenyl sulphone in rabbit urine. Biochem J. 1956; 63(3):406-8. PMC: 1216187. DOI: 10.1042/bj0630406. View

LEVI A, Snow G . Metabolism and excretion of di(p-aminophenyl) sulphoxide in different animal species. Br J Pharmacol Chemother. 1960; 15:160-4. PMC: 1481985. DOI: 10.1111/j.1476-5381.1960.tb01225.x. View

Bushby S, WOIWOD A . Excretion products of 4:4'-diaminodiphenyl sulfone. Am Rev Tuberc. 1955; 72(1):123-5. DOI: 10.1164/artpd.1955.72.1.123. View

DAVEY T, KISSAUN A, Moneta G . The treatment of leprosy with diaminodiphenyl sulphoxide: a progress report. Lepr Rev. 1957; 28(2):51-9. DOI: 10.5935/0305-7518.19570006. View

10.

DAVEY T . Experience with "avlosulfon" soluble. Lepr Rev. 1956; 27(1):6-18. DOI: 10.5935/0305-7518.19560003. View

11.

Titus E, Bernstein J . The pharmacology of the sulfones. Ann N Y Acad Sci. 1949; 52(5):719-28. DOI: 10.1111/j.1749-6632.1949.tb53962.x. View

12.

Buttle G, DEWING T, Foster G, Gray W, Smith S, Stephenson D . The action of substances allied to 4:4'-diaminodiphenylsulphone in streptococcal and other infections in mice. Biochem J. 1938; 32(7):1101-10. PMC: 1264155. DOI: 10.1042/bj0321101. View

13.

Boyer F, TROESTLER J, RIST N, TABONE J . [Research on the mechanism of action of sulfones; II.--Analytic study]. Ann Inst Pasteur (Paris). 1950; 78(1):140-3. View